Vasowatch received $150K from Ben Franklin Technology Partners as part of the company’s $1 million seed funding round to continue development of its platform for predicting postpartum hemorrhage risk. The company was co-founded by Christine Rohan, CEO, Stefanie Modri, MSN, RN, C-MNN, C-OB, Clinical Adjunct Instructor at Penn Nursing, and James Weimer, PhD, former Penn Engineering faculty member and currently Assistant Professor of Computer Science at Vanderbilt University. To learn more about investment opportunities, please contact Christine Rohan.